ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity,supporting
SHANGHAI,Jan. 21,2025--For the seventh consecutive year,Yum China Holdings,Inc. (the "Company" or "Yum China",NYSE: YUMC and HKEX: 9987) has been named as a "2025 China Top Em
SHANGHAI,Jan. 21,2025-- Hesai Technology (Nasdaq: HSAI),the global leader in automotive lidar technology,today announced that it has secured design wins for multiple Chery Automobile models. The model
BANGKOK,Jan. 22,2025-- Thailand is set to make a grand debut at Expo 2025 Osaka,Kansai,Japan,highlighting the country\'s commitment to becoming one of the global leaders in medical and wellness servic
Availability ofDatabricks infrastructure in the Amazon Web Services\' (AWS) Asia Pacific (Jakarta) Region in early 2025
- Contributes Indonesian future talent education through education infrastructure improvement,teaching,and other programs
